The prognostic significance of biomarkers in cerebrospinal fluid following severe traumatic brain injury: a systematic review and meta-analysis
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
The prognostic significance of biomarkers in cerebrospinal fluid following severe traumatic brain injury : a systematic review and meta-analysis. / Hvingelby, Victor Schwartz; Bjarkam, Carsten Reidies; Mathiesen, Tiit Illimar; Poulsen, Frantz Rom; Botker, Morten Thingemann; Husted, Andreas; Korshoej, Anders Rosendal.
I: Neurosurgical Review, Bind 45, 2022, s. 2547–2564.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The prognostic significance of biomarkers in cerebrospinal fluid following severe traumatic brain injury
T2 - a systematic review and meta-analysis
AU - Hvingelby, Victor Schwartz
AU - Bjarkam, Carsten Reidies
AU - Mathiesen, Tiit Illimar
AU - Poulsen, Frantz Rom
AU - Botker, Morten Thingemann
AU - Husted, Andreas
AU - Korshoej, Anders Rosendal
PY - 2022
Y1 - 2022
N2 - After severe traumatic brain injury (sTBI) proteins, neurotrophic factors and inflammatory markers are released into the biofluids. This review and meta-analysis searched the literature for prognostic candidate cerebrospinal fluid markers and their relation to sTBI patient outcome. A systematic search of the literature was carried out across PubMed, EMBASE, PubMed Central (PMC), and Cochrane Central Library. Biomarker concentrations were related to the Glasgow Outcome Scale dichotomized into favorable and unfavorable outcomes. When a biomarker was reported in >= 3 studies, it was included in meta-analysis. The search returned 1527 articles. After full-text analysis, 54 articles were included, 34 from the search, and 20 from the reference lists. Of 9 biomarkers, 8 were significantly different compared to controls (IL-4, IL-6, IL-8, IL-10, TNF alpha, sFas, BDNF, and cortisol). Of these, 5 were significantly increased in sTBI patients with unfavorable outcome (IL-6, IL-8, IL-10, TNF alpha, and cortisol), compared to patients with favorable outcome. This review demonstrated a correlation between 5 biomarkers and clinical outcome in sTBI patients. The paucity of included studies, however, makes it difficult to extrapolate further on this finding.
AB - After severe traumatic brain injury (sTBI) proteins, neurotrophic factors and inflammatory markers are released into the biofluids. This review and meta-analysis searched the literature for prognostic candidate cerebrospinal fluid markers and their relation to sTBI patient outcome. A systematic search of the literature was carried out across PubMed, EMBASE, PubMed Central (PMC), and Cochrane Central Library. Biomarker concentrations were related to the Glasgow Outcome Scale dichotomized into favorable and unfavorable outcomes. When a biomarker was reported in >= 3 studies, it was included in meta-analysis. The search returned 1527 articles. After full-text analysis, 54 articles were included, 34 from the search, and 20 from the reference lists. Of 9 biomarkers, 8 were significantly different compared to controls (IL-4, IL-6, IL-8, IL-10, TNF alpha, sFas, BDNF, and cortisol). Of these, 5 were significantly increased in sTBI patients with unfavorable outcome (IL-6, IL-8, IL-10, TNF alpha, and cortisol), compared to patients with favorable outcome. This review demonstrated a correlation between 5 biomarkers and clinical outcome in sTBI patients. The paucity of included studies, however, makes it difficult to extrapolate further on this finding.
KW - Traumatic brain injury
KW - Severe traumatic brain injury
KW - Biomarker
KW - Theranostics
KW - Glasgow Outcome Score
U2 - 10.1007/s10143-022-01786-4
DO - 10.1007/s10143-022-01786-4
M3 - Review
C2 - 35419643
VL - 45
SP - 2547
EP - 2564
JO - Neurosurgical Review
JF - Neurosurgical Review
SN - 0344-5607
ER -
ID: 315179600